

NCT02715466 comparison:

Summary:
CHIA has 16 criteria while your personal folder has 16 criteria
Total found criteria: 13/16
Total not Found: 3/16
Total Extra: 5
This trial is INVALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Women of child bearing potential must test         │ Women of child bearing potential must test         │
│ negative on standard pregnancy test (urine or      │ negative on standard pregnancy test (urine or      │
│ serum)                                             │ serum)                                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients diagnosed severe sepsis / septic shock at │ Patients diagnosed severe sepsis / septic shock at │
│ admission on Intensive Care Unit who can be        │ admission on Intensive Care Unit who can be        │
│ enrolled within 90 min after admission OR patients │ enrolled within 90 min after admission OR patients │
│ diagnosed severe sepsis / septic shock during      │ diagnosed severe sepsis / septic shock during      │
│ Intensive Care Unit stay who can be enrolled       │ Intensive Care Unit stay who can be enrolled       │
│ within 90 min after diagnosis                      │ within 90 min after diagnosis                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients where antibiotic therapy has already been │ Patients where antibiotic therapy has already been │
│ started (prior to randomization)                   │ started (prior to randomization)                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient who are fluid responsive. Fluid            │ Patient who are fluid responsive. Fluid            │
│ responsiveness is defined as increase of > 10% in  │ responsiveness is defined as increase of \> 10% in │
│ mean arterial pressure (MAP) after passive leg     │ mean arterial pressure (MAP) after passive leg     │
│ raising (PLR)                                      │ raising (PLR)                                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Signed informed consent by patient, legal          │ Signed informed consent by patient, legal          │
│ representative or authorized person or deferred    │ representative or authorized person or deferred    │
│ consent                                            │ consent                                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Administration of HES, dextrane solutions or > 500 │ Administration of HES, dextrane solutions or \>    │
│ ml of Gelatin solutions within the 24 h prior to   │ 500 ml of Gelatin solutions within the 24 h prior  │
│ randomization                                      │ to randomization                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Death expected within the next 48 h (moribund      │ Death expected within the next 48 h (moribund      │
│ patients as defined by ASA = class V)              │ patients as defined by ASA ≥ class V)              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients for whom the need of pressure infusions   │ Patients for whom the need of pressure infusions   │
│ are expected                                       │ are expected                                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Requirement for renal support (either continuous   │ Requirement for renal support (either continuous   │
│ or discontinuous techniques, including             │ or discontinuous techniques, including             │
│ intermittent haemodialysis, haemofiltration and    │ intermittent haemodialysis, haemofiltration and    │
│ haemodiafiltration)                                │ haemodiafiltration)                                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients receiving therapeutic heparin medication  │ Patients receiving therapeutic heparin medication  │
│ due to chronic coagulation disease /               │ due to chronic coagulation disease /               │
│ anticoagulation medication (i.e. partial           │ anticoagulation medication (i.e. partial           │
│ thromboplastin time > 60 sec)                      │ thromboplastin time \> 60 sec)                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Acutely burned patients                            │ Acutely burned patients                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Contraindications according to summary of product  │ Contraindications according to summary of product  │
│ characteristics of investigational test and        │ characteristics of investigational test and        │
│ reference product                                  │ reference product                                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Simultaneous participation in another              │ Simultaneous participation in another              │
│ interventional clinical trial (drugs or medical    │ interventional clinical trial (drugs or medical    │
│ devices studies)                                   │ devices studies)                                   │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



╒═════════════════════════════════════════════════════════════════════════════════════╕
│ CHIA Criteria Not Found in Personal                                                 │
╞═════════════════════════════════════════════════════════════════════════════════════╡
│ Male or female patients = 18 and = 85 years of age                                  │
├─────────────────────────────────────────────────────────────────────────────────────┤
│ Patients with body weight = 55 kg and = 140 kg and body mass index (BMI) = 18 kg/m2 │
├─────────────────────────────────────────────────────────────────────────────────────┤
│ Patients whose medical condition does preclude the PLR manoeuvre                    │
╘═════════════════════════════════════════════════════════════════════════════════════╛



╒══════════════════════════════════════════════════════════════════════════════════════════════════╕
│ Extra Personal Criteria                                                                          │
╞══════════════════════════════════════════════════════════════════════════════════════════════════╡
│ Must have maximum age of 85 Years                                                                │
├──────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Patients with confirmed acute SARS-CoV-2 (COVID-19) infection (as available from routine medical │
│ records/ patient chart)                                                                          │
├──────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Patients with body weight ≤ 140 kg                                                               │
├──────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Must have minimum age of 18 Years                                                                │
├──────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Male or female patients ≥ 18 years of age                                                        │
╘══════════════════════════════════════════════════════════════════════════════════════════════════╛